Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

116
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
116

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

Nature reviews. Clinical oncology·2026
Same author

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

Internal medicine journal·2026
Same author

Persistent Pyelonephritis and Renal Abscess due to <i>Mycoplasma hominis</i> in an Immunocompromised Patient: A Case Report.

Case reports in infectious diseases·2026
Same author

Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population-Based Study of Patients With B-Cell Malignancies.

European journal of haematology·2026
Same author

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

相关实验视频

Updated: Jun 28, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K

初级胃扩散大B细胞淋巴瘤:一个多中心的回顾性研究.

Cameron S Lewis1,2, Greta Joy3,4, Paw Jensen5

  • 1Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

British journal of haematology
|April 18, 2024
PubMed
概括

早期的胃扩散性大B细胞淋巴瘤 (DLBCL) 显示了R-CHOP化疗免疫治疗的良好结果. 临时PET扫描可以准确预测治疗反应,指导局部DLBCL的进一步管理.

关键词:
DLBCL DLBCL 是一个字母.额外的淋巴瘤 额外的淋巴瘤胃 DLBCLL 的情况.胃淋巴瘤 胃淋巴瘤

更多相关视频

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.5K

相关实验视频

Last Updated: Jun 28, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.5K

科学领域:

  • 在瘤学瘤学.
  • 血液学 血液学 血液学
  • 医疗成像医学成像

背景情况:

  • 主要胃扩散性大B细胞淋巴瘤 (PG-DLBCL) 是最常见的外节DLBCL亚型.
  • 有限的文献存在于早期,本地化的PG-DLBCL演示和结果.
  • 了解治疗疗效和预后因素对于这个患者群体至关重要.

研究的目的:

  • 为了描述I期PG-DLBCL患者的结果.
  • 对早期PG-DLBCL的当前治疗策略进行审查.
  • 研究中期正子发射断层扫描 (iPET) 在预测治疗反应中的作用.

主要方法:

  • 在2006-2018年间在六个国际中心诊断出I期PG-DLBCL的37名患者的回顾性分析.
  • 患者接受化学免疫疗法,主要是R-CHOP (利图西马布,环胺,多克索鲁比辛,温克里斯,普雷迪尼索隆).
  • 巩固性放射治疗和Helicobacter pylori (H. pylori) 根除疗法被评估为辅助; iPET扫描被审查.

主要成果:

  • 对R-CHOP的4年无进展生存期 (PFS) 和整体生存期 (OS) 分别为88%和91%.
  • 所有在 iPET 上获得代谢反应的患者在治疗结束时都获得了完整的反应.
  • 在35.1%的患者中使用了巩固性放射治疗;在18名患者中记录了H. pylori状态.

结论:

  • 基于R-CHOP的化疗免疫疗法在第一阶段PG-DLBCL中显示出有利的结果.
  • 临时PET (iPET) 评估是预测早期胃淋巴瘤治疗反应的宝贵工具.
  • 关于放射治疗和H. pylori根除的治疗决定应该是个性化的.